University of California San Francisco
Helen Diller Family Comprehensive Cancer Center
Kathryn A. Phillips, PhD, MPA

Kathryn A. Phillips, PhD, MPA

Professor of Health Services Research and Health Economics, Department of Clinical Pharmacy, School of Pharmacy; Director/Founder, Center for Translational and Policy Research on Personalized Medicine (TRANSPERS), UCSF

Cancer Center Program Memberships

Cancer Control | Cancer Genetics

Research Summary

My research focuses on the value of new technologies, with a specific emphasis on the application of genetics to cancer care and control (“personalized medicine”). In 2008, I founded the UCSF Center for Translational and Policy Research on Personalized Medicine (TRANSPERS), which focuses on how personalized medicine can be most effectively and efficiently be adopted into health care delivery and health policies. I have had continuous funding from the NIH as Principal Investigator for over 20 years, have led or participated in over 50 funded research grants, and have published over 100 peer-reviewed articles in all of the leading journals in health policy. A particular focus is cross-disciplinary/cross-sector research as exemplified by my advisory role to many government and industry organizations.
My work in cancer screening spans almost my entire academic career, with early work on predictors of mammography screening followed by work on colorectal cancer screening. I now work on policy issues relevant to hereditary cancer risk assessment testing and tumor profiling using sequencing technologies. I work closely with the UCSF HDFCCC as a long-time member of the Population Sciences/Cancer Control Program and as the designated leader for comparative effectiveness research. I have presented at multiple IOM, NCI, and other meetings focused on cancer and have published in leading cancer journals. My work has been funded by several cancer organizations, including two R01s and a Program Project Grant (P01) funded by NCI.

Education

University of Texas, Austin, BA, 1978, Psychology
Kennedy School of Government, Harvard Univ., Cambridge, MA, MPA, 1986, Policy Analysis
University of California, Berkeley, PhD, 1991, Health Services Research
Center for AIDS Prevention Studies, Univ. of CA San Francisco, Postdoc, 1993, Health Services Research


Professional Experience

  • 1993-1995
    Assistant Research Professor, University of California, San Francisco (UCSF)
  • 1995-1998
    Assistant Professor (non-tenure track), UCSF
  • 1998-2004
    Associate Professor of Health Economics and Health Services Research, UCSF
  • 2007
    Visiting Scholar, Harvard Partners Center for Genetics and Genomics and New England Health Care Institute, Boston, MA
  • 2004-present
    Professor of Health Economics and Health Services Research (tenured) and Director/Founder, Center for Translational and Policy Research on Personalized Medicine (TRANSPERS), Department of Clinical Pharmacy, School of Pharmacy (home department); Institute for Health Policy Studies & UCSF Comprehensive Cancer Center (affiliated faculty) University of California, San Francisco

Honors & Awards

  • 1977
    Phi Beta Kappa
  • 1985-1986
    Long-Term Civilian Training Award for study at Harvard University, Department of Navy
  • 1987
    Special Achievement Award, Federal Aviation Administration
  • 1987-1988
    University of California-Berkeley Graduate Fellowship
  • 1989
    Outstanding Graduate Student Instructor, University of California-Berkeley
  • 2003
    Named as one of the "50 Most Cited HIV Behavioral Researchers in the Past Decade"
  • 2006
    Nominated to HHS Secretary’s Advisory Committee on Genetics, Health, and Society
  • 2009
    Grollman Lecture at the University of Maryland School of Pharmacy
  • 2010
    Director’s Lecture, National Human Genome Research Institute (NHGRI)

Selected Publications

  1. Phillips KA, Deverka PA, Trosman JR, Douglas MP, Chambers JD, Weldon CB, Dervan AP. Payer coverage policies for multigene tests. Nat Biotechnol. 2017 Jul 12; 35(7):614-617.
    View on PubMed
  2. Phillips KA, Deverka PA, Sox HC, Khoury MJ, Sandy LG, Ginsburg GS, Tunis SR, Orlando LA, Douglas MP. Making genomic medicine evidence-based and patient-centered: a structured review and landscape analysis of comparative effectiveness research. Genet Med. 2017 Apr 13.
    View on PubMed
  3. Trosman JR, Weldon CB, Douglas MP, Kurian AW, Kelley RK, Deverka PA, Phillips KA. Payer Coverage for Hereditary Cancer Panels: Barriers, Opportunities, and Implications for the Precision Medicine Initiative. J Natl Compr Canc Netw. 2017 Feb; 15(2):219-228.
    View on PubMed
  4. Phillips KA. Assessing the Value and Implications of Personalized/Precision Medicine and the "Lessons Learned" for Emerging Technologies: An Introduction. Value Health. 2017 Jan; 20(1):30-31.
    View on PubMed
  5. Trosman JR, Weldon CB, Douglas MP, Deverka PA, Watkins JB, Phillips KA. Decision Making on Medical Innovations in a Changing Health Care Environment: Insights from Accountable Care Organizations and Payers on Personalized Medicine and Other Technologies. Value Health. 2017 Jan; 20(1):40-46.
    View on PubMed
  6. Phillips KA, Douglas MP, Trosman JR, Marshall DA. "What Goes Around Comes Around": Lessons Learned from Economic Evaluations of Personalized Medicine Applied to Digital Medicine. Value Health. 2017 Jan; 20(1):47-53.
    View on PubMed
  7. Dervan AP, Deverka PA, Trosman JR, Weldon CB, Douglas MP, Phillips KA. Payer decision making for next-generation sequencing-based genetic tests: insights from cell-free DNA prenatal screening. Genet Med. 2017 May; 19(5):559-567.
    View on PubMed
  8. Marshall DA, Gonzalez JM, Johnson FR, MacDonald KV, Pugh A, Douglas MP, Phillips KA. What are people willing to pay for whole-genome sequencing information, and who decides what they receive? Genet Med. 2016 Dec; 18(12):1295-1302.
    View on PubMed
  9. Phillips KA, Schleifer D, Hagelskamp C. Most Americans Do Not Believe That There Is An Association Between Health Care Prices And Quality Of Care. Health Aff (Millwood). 2016 Apr; 35(4):647-53.
    View on PubMed
  10. Clain E, Trosman JR, Douglas MP, Weldon CB, Phillips KA. Availability and payer coverage of BRCA1/2 tests and gene panels. Nat Biotechnol. 2015 Sep; 33(9):900-2.
    View on PubMed
  11. Douglas MP, Ladabaum U, Pletcher MJ, Marshall DA, Phillips KA. Economic evidence on identifying clinically actionable findings with whole-genome sequencing: a scoping review. Genet Med. 2016 Feb; 18(2):111-6.
    View on PubMed
  12. Phillips KA, Ladabaum U, Pletcher MJ, Marshall DA, Douglas MP. Key emerging themes for assessing the cost-effectiveness of reporting incidental findings. Genet Med. 2015 Apr; 17(4):314-5.
    View on PubMed
  13. Trosman JR, Weldon CB, Kelley RK, Phillips KA. Challenges of coverage policy development for next-generation tumor sequencing panels: experts and payers weigh in. J Natl Compr Canc Netw. 2015 Mar; 13(3):311-8.
    View on PubMed
  14. Foster DG, Biggs MA, Phillips KA, Grindlay K, Grossman D. Potential public sector cost-savings from over-the-counter access to oral contraceptives. Contraception. 2015 May; 91(5):373-9.
    View on PubMed
  15. Knight SJ, Mohamed AF, Marshall DA, Ladabaum U, Phillips KA, Walsh JM. Value of Genetic Testing for Hereditary Colorectal Cancer in a Probability-Based US Online Sample. Med Decis Making. 2015 Jan 14.
    View on PubMed
  16. Garfeld S, Douglas MP, MacDonald KV, Marshall DA, Phillips KA. Consumer familiarity, perspectives and expected value of personalized medicine with a focus on applications in oncology. Per Med. 2015 Jan 01; 12(1):13-22.
    View on PubMed
  17. Phillips KA, Pletcher MJ, Ladabaum U. Is the ``$1000 Genome'' really $1000? Understanding the full benefits and costs of genomic sequencing. Technol Health Care. 2015; 23(3):373-9.
    View on PubMed
  18. Phillips KA, Labno A. Private Companies Providing Health Care Price Data: Who Are They and What Information do They Provide? J Manag Care Med. 2014 Oct 01; 17(4):75-80.
    View on PubMed
  19. Phillips KA, Trosman JR, Kelley RK, Pletcher MJ, Douglas MP, Weldon CB. Genomic sequencing: assessing the health care system, policy, and big-data implications. Health Aff (Millwood). 2014 Jul; 33(7):1246-53.
    View on PubMed
  20. Balakrishnan N, Pritchard J, Ericson M, Grindem C, Phillips K, Jennings S, Mathews K, Tran H, Birkenheuer AJ, Breitschwerdt EB. Prostatitis, steatitis, and diarrhea in a dog following presumptive flea-borne transmission of Bartonella henselae. J Clin Microbiol. 2014 Sep; 52(9):3447-52.
    View on PubMed

Go to UCSF Profiles, powered by CTSI